Review





Similar Products

90
Cell Applications Inc eg5 monoclonal antibodies
Eg5 Monoclonal Antibodies, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eg5 monoclonal antibodies/product/Cell Applications Inc
Average 90 stars, based on 1 article reviews
eg5 monoclonal antibodies - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Proteintech rabbit anti kif11
Rabbit Anti Kif11, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti kif11/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti kif11 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Proteintech eg5
Impact of 1( R ) and 1( S ) on the motor proteins KIF1C, <t>Eg5,</t> and the microtubule destabilizing protein stathmin. Nuclear DNA is displayed in blue in all images. The scale bar (10 µm) is valid for the respective row of images. A) 1( R ) has no effects on the distribution of KIF1C (green). B) Eg5 (green) is diffusely distributed in mitotic cells treated with 1( R ) . C) 1( R ) treated cells do not show an induction of stathmin (green).
Eg5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eg5/product/Proteintech
Average 93 stars, based on 1 article reviews
eg5 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

95
Proteintech antibodies against kif11
Fig. 6 Correlations between the <t>KIF11</t> expression level and clinical characteristics of patients with EC. A The expression of KIF11 in tumor tissue was significantly greater than that in normal tissue. B The expression of KIF11 in the tumor tissue of patients with EC was significantly greater than that in the corresponding adjacent cancerous tissue. C Differential expression of KIF11 in different histologic grades of EC. D Differential expression of KIF11 in differ ent clinical stages of EC. E Differential expression of KIF11 in different cancer statuses. F Kaplan‒Meier curve for the relationship between KIF11 expression and the prognosis of EC patients
Antibodies Against Kif11, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against kif11/product/Proteintech
Average 95 stars, based on 1 article reviews
antibodies against kif11 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Proteintech membrane
Fig. 6 Correlations between the <t>KIF11</t> expression level and clinical characteristics of patients with EC. A The expression of KIF11 in tumor tissue was significantly greater than that in normal tissue. B The expression of KIF11 in the tumor tissue of patients with EC was significantly greater than that in the corresponding adjacent cancerous tissue. C Differential expression of KIF11 in different histologic grades of EC. D Differential expression of KIF11 in differ ent clinical stages of EC. E Differential expression of KIF11 in different cancer statuses. F Kaplan‒Meier curve for the relationship between KIF11 expression and the prognosis of EC patients
Membrane, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/membrane/product/Proteintech
Average 95 stars, based on 1 article reviews
membrane - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Proteintech kif11
Fig. 6 Correlations between the <t>KIF11</t> expression level and clinical characteristics of patients with EC. A The expression of KIF11 in tumor tissue was significantly greater than that in normal tissue. B The expression of KIF11 in the tumor tissue of patients with EC was significantly greater than that in the corresponding adjacent cancerous tissue. C Differential expression of KIF11 in different histologic grades of EC. D Differential expression of KIF11 in differ ent clinical stages of EC. E Differential expression of KIF11 in different cancer statuses. F Kaplan‒Meier curve for the relationship between KIF11 expression and the prognosis of EC patients
Kif11, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kif11/product/Proteintech
Average 95 stars, based on 1 article reviews
kif11 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Impact of 1( R ) and 1( S ) on the motor proteins KIF1C, Eg5, and the microtubule destabilizing protein stathmin. Nuclear DNA is displayed in blue in all images. The scale bar (10 µm) is valid for the respective row of images. A) 1( R ) has no effects on the distribution of KIF1C (green). B) Eg5 (green) is diffusely distributed in mitotic cells treated with 1( R ) . C) 1( R ) treated cells do not show an induction of stathmin (green).

Journal: Chemmedchem

Article Title: Cytotoxicity of Atropisomeric [1,1′‐Binaphthalene]‐2,2′‐Diamines (BINAM) and Analogs in Human Cancer Cells: Enantioselectivity, Structure–Activity Relationships, and Mechanism

doi: 10.1002/cmdc.202500426

Figure Lengend Snippet: Impact of 1( R ) and 1( S ) on the motor proteins KIF1C, Eg5, and the microtubule destabilizing protein stathmin. Nuclear DNA is displayed in blue in all images. The scale bar (10 µm) is valid for the respective row of images. A) 1( R ) has no effects on the distribution of KIF1C (green). B) Eg5 (green) is diffusely distributed in mitotic cells treated with 1( R ) . C) 1( R ) treated cells do not show an induction of stathmin (green).

Article Snippet: Antibodies used were as follows: Alexa Fluor 488 conjugate (#4412, CST, 1:500), Alexa Fluor 594 conjugate (#8890, CST, 1:500), alpha‐tubulin (#11224‐1‐AP, Proteintech, 1:100), acetyl alpha‐tubulin (#5335, CST, 1:100), centrin (#ZMS1054, Sigma–Aldrich, 1:100), detyrosinated alpha‐tubulin (#abx375026, Abbexa, 1:100), EB1 (#17717‐1‐AP, Proteintech, 1:200), Eg5 (#23333‐1‐AP, Proteintech, 1:200), gamma‐tubulin (#CL594‐66320, Proteintech, 1:100), KIF1C (#12760‐1‐AP, Proteintech, 1:100), stathmin 1 (#11157‐1‐AP, Proteintech, 1:100).

Techniques:

Fig. 6 Correlations between the KIF11 expression level and clinical characteristics of patients with EC. A The expression of KIF11 in tumor tissue was significantly greater than that in normal tissue. B The expression of KIF11 in the tumor tissue of patients with EC was significantly greater than that in the corresponding adjacent cancerous tissue. C Differential expression of KIF11 in different histologic grades of EC. D Differential expression of KIF11 in differ ent clinical stages of EC. E Differential expression of KIF11 in different cancer statuses. F Kaplan‒Meier curve for the relationship between KIF11 expression and the prognosis of EC patients

Journal: Journal of translational medicine

Article Title: Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer.

doi: 10.1186/s12967-025-06081-6

Figure Lengend Snippet: Fig. 6 Correlations between the KIF11 expression level and clinical characteristics of patients with EC. A The expression of KIF11 in tumor tissue was significantly greater than that in normal tissue. B The expression of KIF11 in the tumor tissue of patients with EC was significantly greater than that in the corresponding adjacent cancerous tissue. C Differential expression of KIF11 in different histologic grades of EC. D Differential expression of KIF11 in differ ent clinical stages of EC. E Differential expression of KIF11 in different cancer statuses. F Kaplan‒Meier curve for the relationship between KIF11 expression and the prognosis of EC patients

Article Snippet: Next, the membrane was incubated overnight at 4 °C with primary antibodies against KIF11 (1:1000; Catalog # 23333-1-AP; Proteintech, Wuhan, China).

Techniques: Expressing, Quantitative Proteomics

Fig. 7 Validation of KIF11 expression in clinical samples. A HE staining of cancer tissues and adjacent tissues from patients with EC. B RT‒qPCR detection of KIF11 expression levels in cancer tissues and adjacent tissues. C Differential expression of KIF11 in cancer and adjacent tissues detected by IHC. Scale bar, 100 μm

Journal: Journal of translational medicine

Article Title: Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer.

doi: 10.1186/s12967-025-06081-6

Figure Lengend Snippet: Fig. 7 Validation of KIF11 expression in clinical samples. A HE staining of cancer tissues and adjacent tissues from patients with EC. B RT‒qPCR detection of KIF11 expression levels in cancer tissues and adjacent tissues. C Differential expression of KIF11 in cancer and adjacent tissues detected by IHC. Scale bar, 100 μm

Article Snippet: Next, the membrane was incubated overnight at 4 °C with primary antibodies against KIF11 (1:1000; Catalog # 23333-1-AP; Proteintech, Wuhan, China).

Techniques: Biomarker Discovery, Expressing, Staining, Quantitative Proteomics

Fig. 8 Effect of KIF11 knockdown on the proliferation of EC cells. The KIF11 knockdown efficiency in the EC cell line ISHIKAWA was determined by RT‒ qPCR (A) and Western blotting (B and C). The KIF11 knockdown efficiency in the EC cell line HEC-1-B was determined by RT‒qPCR (D) and Western blot ting (E and F). G The proliferation of tumor cells after KIF11 knockdown was detected via the MTT assay. **p < 0.01, ***p < 0.001, ****p < 0.0001

Journal: Journal of translational medicine

Article Title: Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer.

doi: 10.1186/s12967-025-06081-6

Figure Lengend Snippet: Fig. 8 Effect of KIF11 knockdown on the proliferation of EC cells. The KIF11 knockdown efficiency in the EC cell line ISHIKAWA was determined by RT‒ qPCR (A) and Western blotting (B and C). The KIF11 knockdown efficiency in the EC cell line HEC-1-B was determined by RT‒qPCR (D) and Western blot ting (E and F). G The proliferation of tumor cells after KIF11 knockdown was detected via the MTT assay. **p < 0.01, ***p < 0.001, ****p < 0.0001

Article Snippet: Next, the membrane was incubated overnight at 4 °C with primary antibodies against KIF11 (1:1000; Catalog # 23333-1-AP; Proteintech, Wuhan, China).

Techniques: Knockdown, Western Blot, MTT Assay

Fig. 9 Effect of KIF11 knockdown on the migration and invasion of EC cell lines. Wound healing assays revealed that KIF11 knockdown reduced the migration ability of ISHIKAWA (A) and HEC-1-B (B) cells 24 h after transfection. Transwell analysis revealed that KIF11 knockdown reduced the invasion of ISHIKAWA (C) and HEC-1-B (D) cells. **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar, 200 μm

Journal: Journal of translational medicine

Article Title: Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer.

doi: 10.1186/s12967-025-06081-6

Figure Lengend Snippet: Fig. 9 Effect of KIF11 knockdown on the migration and invasion of EC cell lines. Wound healing assays revealed that KIF11 knockdown reduced the migration ability of ISHIKAWA (A) and HEC-1-B (B) cells 24 h after transfection. Transwell analysis revealed that KIF11 knockdown reduced the invasion of ISHIKAWA (C) and HEC-1-B (D) cells. **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar, 200 μm

Article Snippet: Next, the membrane was incubated overnight at 4 °C with primary antibodies against KIF11 (1:1000; Catalog # 23333-1-AP; Proteintech, Wuhan, China).

Techniques: Knockdown, Migration, Transfection

Fig. 10 Effects of KIF11 knockdown on the cell cycle and apoptosis in EC cell lines were examined by flow cytometry. KIF11 knockdown increased the proportion of ISHIKAWA (A) and HEC-1-B (B) cells in the G2/M phase. The increased rate of apoptosis in ISHIKAWA (C) and HEC-1-B (D) cells after KIF11 siRNA transfection. ** p < 0.01, *** p < 0.001

Journal: Journal of translational medicine

Article Title: Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer.

doi: 10.1186/s12967-025-06081-6

Figure Lengend Snippet: Fig. 10 Effects of KIF11 knockdown on the cell cycle and apoptosis in EC cell lines were examined by flow cytometry. KIF11 knockdown increased the proportion of ISHIKAWA (A) and HEC-1-B (B) cells in the G2/M phase. The increased rate of apoptosis in ISHIKAWA (C) and HEC-1-B (D) cells after KIF11 siRNA transfection. ** p < 0.01, *** p < 0.001

Article Snippet: Next, the membrane was incubated overnight at 4 °C with primary antibodies against KIF11 (1:1000; Catalog # 23333-1-AP; Proteintech, Wuhan, China).

Techniques: Knockdown, Flow Cytometry, Transfection